Soni, UK; Roychoudhury, K; Hegde, RS.
The Eyes Absent proteins in development and in developmental disorders.
Biochemical Society Transactions.
2021;
49:1397-1408.
Sun, F; Wang, G; Pradhan, A; Xu, K; Gomez-Arroyo, J; Zhang, Y; Kalin, GT; Deng, Z; Vagnozzi, RJ; He, H; et al.
Nanoparticle Delivery of STAT3 Alleviates Pulmonary Hypertension in a Mouse Model of Alveolar Capillary Dysplasia.
Circulation.
2021.
Wang, Y; Pandey, RN; Roychoudhury, K; Milewski, D; Kalin, TV; Szabo, S; Pressey, JG; Hegde, RS.
Targeting EYA3 in Ewing Sarcoma Retards Tumor Growth and Angiogenesis.
Molecular Cancer Therapeutics.
2021;
20:803-815.
Roychoudhury, K; Hegde, RS.
The Eyes Absent Proteins: Unusual HAD Family Tyrosine Phosphatases.
International Journal of Molecular Sciences.
2021;
22.
Hegde, RS; Roychoudhury, K; Pandey, RN.
The multi-functional eyes absent proteins.
Critical Reviews in Biochemistry and Molecular Biology.
2020;
55:372-385.
Abe, H; Alavattam, KG; Hu, Y; Pang, Q; Andreassen, PR; Hegde, RS; Namekawa, SH.
The Initiation of Meiotic Sex Chromosome Inactivation Sequesters DNA Damage Signaling from Autosomes in Mouse Spermatogenesis.
Current Biology.
2020;
30:408-420.e5.
Wang, Y; Pandey, RN; York, AJ; Mallela, J; Nichols, WC; Hu, Y; Molkentin, JD; Wikenheiser-Brokamp, KA; Hegde, RS.
The EYA3 tyrosine phosphatase activity promotes pulmonary vascular remodeling in pulmonary arterial hypertension.
Nature Communications.
2019;
10.
Nguyen, MT; Vemaraju, S; Nayak, G; Odaka, Y; Buhr, ED; Alonzo, N; Tran, U; Batie, M; Upton, BA; Darvas, M; et al.
An opsin 5-dopamine pathway mediates light-dependent vascular development in the eye.
Nature Cell Biology.
2019;
21:420-429.
Wang, Y; Pandey, RN; Riffle, S; Chintala, H; Wikenheiser-Brokamp, KA; Hegde, RS.
The Protein Tyrosine Phosphatase Activity of Eyes Absent Contributes to Tumor Angiogenesis and Tumor Growth.
Molecular Cancer Therapeutics.
2018;
17:1659-1669.
Riffle, S; Pandey, RN; Albert, M; Hegde, RS.
Linking hypoxia, DNA damage and proliferation in multicellular tumor spheroids.
BMC Cancer.
2017;
17.
Riffle, S; Hegde, RS.
Modeling tumor cell adaptations to hypoxia in multicellular tumor spheroids.
Journal of Experimental and Clinical Cancer Research.
2017;
36.
Wang, Y; Tadjuidje, E; Pandey, RN; III, SJ A; Smith, LE H; Lang, RA; Hegde, RS.
The Eyes Absent Proteins in Developmental and Pathological Angiogenesis.
American Journal of Pathology.
2016;
186:568-578.
Tadjuidje, E; Hegde, RS.
The Eyes Absent proteins in development and disease.
Cellular and Molecular Life Sciences.
2013;
70:1897-1913.
Rao, S; Chun, C; Fan, J; Kofron, JM; Yang, MB; Hegde, RS; Ferrara, N; Copenhagen, DR; Lang, RA.
A direct and melanopsin-dependent fetal light response regulates mouse eye development.
Nature: New biology.
2013;
494:243-246.
Tadjuidje, E; Sen Wang, T; Pandey, RN; Sumanas, S; Lang, RA; Hegde, RS.
The EYA tyrosine phosphatase activity is pro-angiogenic and is inhibited by benzbromarone.
PLoS ONE.
2012;
7.
Pandey, RN; Rani, R; Yeo, E; Spencer, M; Hu, S; Lang, RA; Hegde, RS.
The Eyes Absent phosphatase-transactivator proteins promote proliferation, transformation, migration, and invasion of tumor cells.
Oncogene.
2010;
29:3715-3722.
Rayapureddi, JP; Kattamuri, C; Steinmetz, BD; Frankfort, BJ; Ostrin, EJ; Mardon, G; Hegde, RS.
Eyes absent represents a class of protein tyrosine phosphatases.
Nature: New biology.
2003;
426:295-298.